Seung Jae Huh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Seung Jae Huh has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
W. Park
7 shared publicationsDo Hoon Lim
4 shared publicationsWon Park
4 shared publicationsY C Ahn
4 shared publicationsD H Lim
3 shared publicationsD.H. Choi
3 shared publications
Latest Publications
- Open Access
- 1 May 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 123, S636-S637
EP-1172: Post-mastectomy radiotherapy with patient-tailored bolus using 3D printing for left breast cancer
- 1 May 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 123, S636-S637
Open AccessEP-1172: Post-mastectomy radiotherapy with patient-tailored bolus using 3D printing for left breast cancer
- 30 September 2011
- Published by Elsevier in European Journal of Cancer
- Vol. 47, S389
5197 POSTER Prognostic Value of Age at Diagnosis is Prognostic Factors in Young Women With Breast Cancer in Korea
- 30 September 2011
- Published by Elsevier in European Journal of Cancer
- Vol. 47, S389
5197 POSTER Prognostic Value of Age at Diagnosis is Prognostic Factors in Young Women With Breast Cancer in Korea
- 30 September 2011
- Published by Elsevier in European Journal of Cancer
- Vol. 47, S418-S419
6092 POSTER Oxaliplatin/5-Fluorouracil/Leucovorin in Colorectal Cancer With Malignant Ascites, an Observational Study
- 30 September 2011
- Published by Elsevier in European Journal of Cancer
- Vol. 47, S418-S419
6092 POSTER Oxaliplatin/5-Fluorouracil/Leucovorin in Colorectal Cancer With Malignant Ascites, an Observational Study
- 20 May 2011
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (15) , 1097
Prognostic index for patients with brain metastases from breast cancer: A validation and refinement of the breast-specific graded prognostic assessment (GPA) index.
1097 Background: Breast cancer (BC) is the second most common cause of brain metastases (BM). Various prognostic indexes such as RPA to predict survival in BM patients have been developed in patients enrolled in RTOG trials. However, they did not predict BC specific-survival with BM accurately because they had mostly included lung cancer patients. BC specific graded prognostic assessment (GPA) has been developed (Sperduto et al., IJROBP. 2010) and modified (ASCO 2010 abst. #1028) to reflect unique biologic feature of BC. The purpose of this study is to appraise and refine the Sperduto’s BC-specific GPA index (S’ GPA). Methods: We retrospectively investigated 272 patients with BM from BC between 1995 and 2009 at Samsung Medical Center. 173 of 272 patients who had available clinical data with ER, PR, and HER2 status were included. We appraised the S’ GPA index in our cohort. Since treatment with trastuzumab significantly enhanced survival of HER2 overexpressing BC patients with BM, we refined the S’ GPA index as shown in the table. Then, we validated our refined BC-specific GPA index with external patients’ cohort (n=140). Results: Overall median survival time (MST) for 173 patients was 9.4 months. However, Sperduto’s GPA index did not predict survival of BC with BM accurately in our patients’ cohort. The patients with our refined GPA scores of 0-1.0, 1.5-2.0, 2.5-3.0, and 3.5-4.0 showed significant discrimination in MST with 6.0 (n=22), 8.6 (n=76), 11.4 (n=60), 14.1 (n=15) months (p=0.004), respectively. Our refined GPA index was validated with external patients’ cohort at Yonsei Cancer Center. It did predict survival of BC with BM accurately in validation cohort according to refined GPA scores (p<0.001). Conclusions: The Sperduto’s GPA index was not appraisable for predicting survival of BC with BM in the era of trastuzumab. Refining the BC specific GPA index incorporated with trastuzumab treatment is proposed to be a prognostic tool with better predictive value.
- 20 May 2011
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (15) , 1097
Prognostic index for patients with brain metastases from breast cancer: A validation and refinement of the breast-specific graded prognostic assessment (GPA) index.
1097 Background: Breast cancer (BC) is the second most common cause of brain metastases (BM). Various prognostic indexes such as RPA to predict survival in BM patients have been developed in patients enrolled in RTOG trials. However, they did not predict BC specific-survival with BM accurately because they had mostly included lung cancer patients. BC specific graded prognostic assessment (GPA) has been developed (Sperduto et al., IJROBP. 2010) and modified (ASCO 2010 abst. #1028) to reflect unique biologic feature of BC. The purpose of this study is to appraise and refine the Sperduto’s BC-specific GPA index (S’ GPA). Methods: We retrospectively investigated 272 patients with BM from BC between 1995 and 2009 at Samsung Medical Center. 173 of 272 patients who had available clinical data with ER, PR, and HER2 status were included. We appraised the S’ GPA index in our cohort. Since treatment with trastuzumab significantly enhanced survival of HER2 overexpressing BC patients with BM, we refined the S’ GPA index as shown in the table. Then, we validated our refined BC-specific GPA index with external patients’ cohort (n=140). Results: Overall median survival time (MST) for 173 patients was 9.4 months. However, Sperduto’s GPA index did not predict survival of BC with BM accurately in our patients’ cohort. The patients with our refined GPA scores of 0-1.0, 1.5-2.0, 2.5-3.0, and 3.5-4.0 showed significant discrimination in MST with 6.0 (n=22), 8.6 (n=76), 11.4 (n=60), 14.1 (n=15) months (p=0.004), respectively. Our refined GPA index was validated with external patients’ cohort at Yonsei Cancer Center. It did predict survival of BC with BM accurately in validation cohort according to refined GPA scores (p<0.001). Conclusions: The Sperduto’s GPA index was not appraisable for predicting survival of BC with BM in the era of trastuzumab. Refining the BC specific GPA index incorporated with trastuzumab treatment is proposed to be a prognostic tool with better predictive value.
- 1 November 2010
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 78 (3) , S242
Omitting Postoperative Radiation after Excision for Ductal Carcinoma In Situ of the Breast
- 1 November 2010
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 78 (3) , S242
Omitting Postoperative Radiation after Excision for Ductal Carcinoma In Situ of the Breast
- 1 January 2007
- Published by Elsevier in Gynecologic Oncology
- Vol. 104 (1) , 145-151
Interfractional variation of uterine position during radical RT: Weekly CT evaluation
- 1 January 2007
- Published by Elsevier in Gynecologic Oncology
- Vol. 104 (1) , 145-151
Interfractional variation of uterine position during radical RT: Weekly CT evaluation
- 17 November 2005
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 15 (6) , 1166-1168
A case of alveolar soft part sarcoma with vaginal metastasis: successful control of vaginal bleeding with external beam irradiation
- 17 November 2005
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 15 (6) , 1166-1168
A case of alveolar soft part sarcoma with vaginal metastasis: successful control of vaginal bleeding with external beam irradiation
- Open Access
- 15 July 2005
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 35 (8) , 470-474
Impact of an Electronic Chart on the Staff Workload in a Radiation Oncology Department
Background: In order to improve the efficiency of patient care, we developed an electronic medical record system, named the Comprehensive Radiation Oncology Management System (C-ROMS). C-ROMS was used together with a commercial record-and-verify system, LANTIS (Siemens Medical Systems Inc., Concord, CA, USA). The impact of the C-ROMS/LANTIS system on the staff workload in the Radiation Oncology Department was quantified and evaluated. Methods: Thirty-four breast cancer patients were divided into two groups based on the method of the charting and the delivery of radiation treatment. The paper chart and manual treatment were used for one group, and the C-ROMS/LANTIS for the other. For each group of patients, the workload per patient for each staff group in the department—nursing/clerical staff, simulation staff, dosimetry/physics staff and technologist staff—was measured and compared. Results: The average total staff workload with the C-ROMS/LANTIS system was 28.2% less than that with the paper chart/manual treatment method. The workloads for nursing/clerical staff, simulation staff and technologist staff were reduced by 85.7, 61.2 and 20.6%, respectively. The workload for dosimetry/physics staff was increased by 28.4%. Conclusion: The C-ROMS/LANTIS system significantly decreased the averaged total staff workload, and thus increased the efficiency of patient care.
- 15 July 2005
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 35 (8) , 470-474
Open AccessImpact of an Electronic Chart on the Staff Workload in a Radiation Oncology Department
Background: In order to improve the efficiency of patient care, we developed an electronic medical record system, named the Comprehensive Radiation Oncology Management System (C-ROMS). C-ROMS was used together with a commercial record-and-verify system, LANTIS (Siemens Medical Systems Inc., Concord, CA, USA). The impact of the C-ROMS/LANTIS system on the staff workload in the Radiation Oncology Department was quantified and evaluated. Methods: Thirty-four breast cancer patients were divided into two groups based on the method of the charting and the delivery of radiation treatment. The paper chart and manual treatment were used for one group, and the C-ROMS/LANTIS for the other. For each group of patients, the workload per patient for each staff group in the department—nursing/clerical staff, simulation staff, dosimetry/physics staff and technologist staff—was measured and compared. Results: The average total staff workload with the C-ROMS/LANTIS system was 28.2% less than that with the paper chart/manual treatment method. The workloads for nursing/clerical staff, simulation staff and technologist staff were reduced by 85.7, 61.2 and 20.6%, respectively. The workload for dosimetry/physics staff was increased by 28.4%. Conclusion: The C-ROMS/LANTIS system significantly decreased the averaged total staff workload, and thus increased the efficiency of patient care.